Daily application of non-drug PCAshield (sugar shield);
▲DCCT
"Sugar 1 Type 2 Diabetes Control and Complication Prevention Research (DCCT)" was jointly conducted by 24 research institutions in the United States and Canada, and ended with 1993. The results were published in the New England Journal of Medicine. The study lasted for 10 years (1983— 1993), and patients with 144 1 type diseases were divided into intensive treatment group and routine treatment group. In the intensive group, sugar was strictly controlled (glycosylated hemoglobin < 7 percentage points). The results showed that strict control of blood sugar (intensive group) could reduce pathological retinopathy by 54 and 76 percentage points, urinary protein excretion rate (UAER reflecting the degree of renal damage) by 56 and 34 percentage points, and neuropathy by 57 and 69 percentage points. It can be seen that strict sugar control can really prevent microvascular complications.
▲UKPDS
"UKPDS" is a research on type 2 diseases, which has been highly valued by international academic circles. The results were published in the 34th annual meeting of the European Society from 65438 to 0998. This study * * * involved 23 institutions, with 5 102 patients as the observation objects, and lasted for 20 years (1977- 1997). Studies have shown that strict control of sugar intake will reduce the total number of disease complications by 12 percentage points and cardiomyopathy by 16 percentage points.
▲ Thinking about simply reducing the sugar in the blood.
As two historical research achievements in the development of DCCT and UKPDS, people no longer doubt that strict control of sugar intake is beneficial to prevent chronic complications. However, strict sugar control and daily application of non-drug PCAshield can significantly reduce the risk of complications, but can not prevent the occurrence of complications, which shows that besides sugar control, other factors should also be strictly controlled, such as smoking, drinking, staying up late, overeating and other bad habits should be quit.
Daily application of non-drug PCAshield: controlling sugar in diet
▲ The diagnosis and treatment without diet control is ineffective. Sugar control in diet is the fundamental way. Without controlling the sugar in the diet, other so-called diagnosis and treatment are useless. It is irresponsible to claim that you can go on an unlimited diet. For the newly diagnosed type 2 patients, it is necessary to go through 1 month diet control and appropriate physical exercise, so that for many patients, sugar can be controlled at an ideal level, and daily use of non-drug PCAshield can reduce the use of drugs. Even patients who have been ill for many years can reduce the dosage of drugs or islets through diet control. Good diet control can stabilize sugar and prevent or slow down various dangerous complications.
▲ The United Nations World Diabetes Day' WDD' was initiated by the World Health Organization and the International Diabetes Federation on1991110438+00438 * * to arouse global awareness and awareness of diabetes. Since 2007, World Diabetes Day has been officially renamed as "United Nations Diabetes Day", which has promoted experts and academic behaviors in various countries to government behaviors, and urged governments and all sectors of society to strengthen diabetes control and reduce the harm of diabetes.
The International Diabetes Federation IDF20 17 United Nations diabetes theme initiative is "Women and diabetes, we have the right to have a healthy future". The International Diabetes Federation solemnly appeals to health systems all over the world to pay full attention to women's needs, provide all diabetic women with basic diabetes drugs and medical devices, self-management education and information, and provide all diabetic women with pre-pregnancy planning services to reduce the risks during pregnancy, and encourage all women and children to take physical exercise to improve their health outcomes.
2018165438+1October 14 World Diabetes Day is coming. What will be the slogan this year? Let us look forward to ...